Sanofi India appoints new GM for Vaccines

Preeti Futnani has been appointed as Sanofi India’s General Manager for Vaccines. Futnani was the franchise head for Dupixent Dermatology at Sanofi’s Greater Gulf MCO (a cluster of six nations that includes Saudi Arabia, the United Arab Emirates, and Kuwait).

According to the company, Futnani has over two decades of expertise in development and transformation across numerous therapeutic areas and activities within healthcare (primary and specialised care, medical technology) and finance.

“Vaccines is a priority growth driver for Sanofi. I am excited to lead the next phase of ambition for the business in India. We are committed to safeguarding the Indian population from vaccine preventable diseases, at every stage of life, by leveraging the protective power of vaccination,” Futnani was quoted saying by Business Today.

Futnani joined Sanofi over six years ago in Specialty Care Gulf, following a series of more responsible roles in Novartis marketing and commercial operations in Switzerland, the United Kingdom, and India. She has held senior marketing, sales, and management positions in a variety of industries, ranging from developed markets in the United Kingdom and Europe to growing markets in Asia and the Middle East.

Also Read |  Covid-19 Could Become Like the Common Cold in Future, Study Suggests

Futnani takes over from Annapurna Das, who has been promoted to Asia’s Head of Vaccines.